BHR Pharmaceuticals logo link to Home Page
 
 
 
 
 
 
 
 
   
   
   
   
ActimPARTUS

ActomPARTUS

ActimPARTUS is a fast and simple bedside test to measure the ripeness of the cervix during pregnancy.

It is an immunochromatographic dipstick test that detects the presence of phosphorylated form of IGFBP-1 (insulin-like growth factor binding protein-1) in cervical secretions.

According to several studies, the level of phosphorylated IGFBP-1 rises considerably as the cervix matures. ActimPARTUS can, therefore, be used to estimate if true term or pre-term labour has actually started.

Most body fluids potentially contaminating a cervical sample, such as semen and urine, contain only trace quantities of phosphorylated IGFBP-1, so the level of phosphorylated IGFBP-1 in an essentially blood-free cervical secretion sample is a clear indication of a ripening cervix.

Typically the ActimPROM test is first used to rule out possible membrane rupture, followed by the ActimPARTUS test to estimate the maturity of the cervix.

BHR Pharmaceuticals Ltd
41, Centenary Business Centre, Hammond Close, Nuneaton, Warwickshire CV11 6RY
: t : +44 (0) 870 0349 606 : : f : +44 (0) 870 0349 607 : : e : info@bhr.co.uk :